Nausea: Clinical Trials

41 trials for Nausea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed. 41 Phase 1, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 141Completed 41
Phase 29Completed 9

Follow Nausea: new trials by email Literature Review of Nausea trials Research Report on Nausea

Trials (filtered) newest first · largest first

All 41 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I PK and Safety Study of Ondansetron Inhalation Powder
LPI-1503, Matching Placebo of LPI-1503, IV Ondansetron - Postoperative Nausea and Vomiting
Phase 1CompletedLuxena Pharmaceuticals, Inc.242025-03-132026-03-27
Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients
Placebo, Magnesium - Hemodynamics Instability, Pain After Surgery
Phase 1 / Phase 2CompletedZiauddin University602025-01-062026-09-02
Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin Under Fed Conditions in Healthy Volunteers
Doxylamine + Pyridoxine, Diclectin - Nausea
Phase 1CompletedValenta Pharm JSC282024-02-272025-07-11
Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation
Glycopyrrolate, Anisodamine - Nausea and Vomiting
Phase 1 / Phase 2CompletedJie Chen1302023-10-012024-09-05
Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting
Lavender Oil, Mandarin Oil, Peppermint oil - Suffering, Physical, Nausea
Phase 1CompletedThe University of Texas Health Science Center at San Antonio1652022-05-162026-06-16
Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children
Dexamethasone, Ondansetron, Dexmedetomidine - Postoperative Nausea and Vomiting, Post Operative Pain
Phase 1CompletedTanta University42021-10-272022-04-05
Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.
Sancuso - Part 1, Sancuso - Part 2 - Healthy Volunteers
Phase 1CompletedKyowa Kirin, Inc.1342021-07-062024-06-14
Olanzapine for the Prevention of Postoperative Nausea and Vomiting
Placebo, 5 mg Olanzapine Tablets, 10 mg Olanzapine Tablets - Postoperative Nausea
Phase 1 / Phase 2CompletedAmani Hassan Abdel-Wahab1322021-03-152023-03-09
The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy
Cannabidiol - Lean Body Mass, Cannabis
Phase 1CompletedUniversity of Copenhagen322020-12-012023-07-24
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
Bremelanotide, Zofran, Placebo - Nausea
Phase 1CompletedAMAG Pharmaceuticals, Inc.2282019-06-172022-04-04
Study of APD421 With and Without Ondansetron
APD421, Placebo, Ondansetron - Postoperative Nausea and Vomiting
Phase 1CompletedAcacia Pharma Ltd302018-07-172018-10-01
Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers
GNS Spray 0.5mg, GNS Spray 1.0mg, GNS Spray 2.0mg - Cancer
Phase 1CompletedMaxinase Life Sciences Ltd.502015-09-012016-01-08
A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route
CL-108, M366, Placebo - Pain, Nausea
Phase 1CompletedCharleston Laboratories, Inc402015-06-012019-10-14
Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
Exenatide - Obesity
Phase 1CompletedGlaxoSmithKline102013-05-162017-10-19
How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women
Ondansetron - Postoperative Nausea
Phase 1 / Phase 2CompletedStanford University1002013-01-012015-06-01
Acupuncture Treatment for Gastroparesis: a Pilot Study
Acupuncture for gastroparesis, Acupuncture for musculoskeletal pain - Gastroparesis, Nausea
Phase 1 / Phase 2CompletedJohns Hopkins University202011-11-012016-09-02
To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects
ondansetron, moxifloxacin, saline - Nausea and Vomiting, Chemotherapy-Induced
Phase 1CompletedGlaxoSmithKline602011-08-162017-11-13
10% Carbohydrate Drink for Preventing Post-operative Nausea and Vomiting (PONV) After Spinal Morphine
10% carbohydrate drink - Nausea and Vomiting, Postoperative
Phase 1CompletedMahidol University1202011-02-012013-07-19
Transcutaneous Electroacupuncture for Gastroparesis
TEA, Sham-TEA - Diabetic Gastroparesis
Phase 1CompletedTranstimulation Research, Inc262010-03-012017-05-01
Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults
Rotavin - Diarrhea, Vomit
Phase 1CompletedNational Institute of Hygiene and Epidemiology, Vietnam292009-08-012016-07-04

Showing 20 of 41. Sign in to see all of them.

Narrower conditions

Vomiting (23)  ·  Postoperative Nausea and Vomiting (11)  ·  Pain (3)  ·  Anorexia (2)  ·  Gastroparesis (2)  ·  Neoplasms (2)  ·  Abdominal Pain (1)  ·  Appetitive Behavior (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Cachexia (1)  ·  Diarrhea (1)  ·  Dysgeusia (1)  ·  Emergence Delirium (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (41)  ·  Signs and Symptoms (41)  ·  Signs and Symptoms, Digestive (41)  ·  Pathologic Processes (11)  ·  Postoperative Complications (11)  ·  Vomiting (9)  ·  Neurologic Manifestations (7)  ·  Body Weight (3)  ·  Digestive System Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Body Weight Changes (2)  ·  Gastrointestinal Diseases (2)

Interventions

Ondansetron (14)  ·  casopitant (7)  ·  Aprepitant (3)  ·  Dexamethasone (2)  ·  Granisetron (2)  ·  Ketoconazole (2)  ·  Tablets (2)  ·  halofantrine (2)  ·  Acupressure (1)  ·  Acupuncture Therapy (1)  ·  Cannabidiol (1)  ·  Control Groups (1)  ·  Cyclophosphamide (1)  ·  Dexmedetomidine (1)  ·  Docetaxel (1)

Sponsors

GlaxoSmithKline (9)  ·  Forest Laboratories (3)  ·  Merck Sharp & Dohme LLC (2)  ·  Sandoz (2)  ·  AMAG Pharmaceuticals, Inc. (1)  ·  Acacia Pharma Ltd (1)  ·  Amani Hassan Abdel-Wahab (1)  ·  Charleston Laboratories, Inc (1)  ·  Duke University (1)  ·  Jie Chen (1)  ·  Johns Hopkins University (1)  ·  Kyowa Kirin, Inc. (1)  ·  Luxena Pharmaceuticals, Inc. (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mahidol University (1)

Countries

United States (21)  ·  Canada (3)  ·  Brazil (1)  ·  China (1)  ·  Denmark (1)  ·  Egypt (1)  ·  India (1)  ·  Mexico (1)  ·  Pakistan (1)  ·  Russia (1)  ·  Saudi Arabia (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)

Top investigators

Eric Sicard, M.D. (3)  ·  Soran Hong, M.D. (2)  ·  Agop Y. Bedikian, MD (1)  ·  Amani H Abdel-wahab, MD (1)  ·  Anh D Dang, PhD (1)  ·  Bernard P Schachtel, M.D (1)  ·  Bianca Gonzales, OTR, CNT, EdD, MOT (1)  ·  Christine M. Walko, PharmD, BCOP (1)  ·  David R. Drover, MD (1)  ·  Deborah H Allen, MSN, RN, CNS, FNP-BC, AOCNP (1)  ·  Dr Asma A Salam, MBBS, FCPS (1)

Results publications

PMID 17513629, PMID 19205754, PMID 19617379, PMID 20220045, PMID 20579837, PMID 22096279, PMID 22245954, PMID 22520120, PMID 23904932, PMID 25670522, PMID 25885838, PMID 26160357, PMID 31303716, PMID 31862004, PMID 31913911, PMID 32839657, PMID 40856942

NIH funding

2008 (1), P30CA016086 (1), R43AT004489 (1)